Original Study| Volume 14, ISSUE 4, e379-e385, August 2016

Local Recurrence After Curative Surgical Treatment of Renal Cell Cancer: A Study of 91 Patients

Published:February 05, 2016DOI:



      Local recurrence (LR) after curative therapy for renal cell cancer is a rare event, and surgery is still the primary treatment option.

      Patients and Methods

      This was a single-institution, single-arm retrospective study from a prospectively conducted database. A total of 91 patients with a median age of 63.0 years (interquartile range, 57.5-68.3), who had undergone LR resection after initial curative treatment of RCC were enrolled. The time to LR (TTLR) was defined as the interval from primary curative surgery to LR. Cancer-specific survival, overall survival, and progression-free survival were evaluated after LR resection. Statistical analyses of the clinical and pathologic variables were performed using Cox regression analysis and the Kaplan-Meier method.


      The median time to LR was 29.8 months (interquartile range, 10.8-64.3). On multivariate analysis, age > 65 years, T3/T4 stage, Fuhrman grade 3/4, major venous infiltration, and positive surgical margins were related to early LR after primary curative surgery. LR size of ≤ 7 cm and TTLR of > 24 months were associated with longer cancer-specific survival. Furthermore, patients with a TTLR of > 24 months had better overall survival and progression-free survival. Of the entire cohort, intraoperative radiation therapy and targeted therapy were used in 17 (18.7%) and 15 (16.5%) patients, respectively.


      Advanced age, T3/T4 stage, Fuhrman grade 3 or 4, major venous infiltration, and positive surgical margins at primary tumor resection were related to a greater risk of early LR. An LR size of ≤ 7 cm and TTLR of > 24 months were associated with favorable oncologic outcomes after LR resection. Thus, patients who present with a longer TTLR and smaller LR size, along with favorable features at primary tumor resection, will benefit from surgical treatment.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Genitourinary Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Jonasch E.
        • Gao J.
        • Rathmell W.K.
        Renal cell carcinoma.
        BMJ. 2014; 349: g4797
        • Ferlay J.
        • Steliarova-Foucher E.
        • Lortet-Tieulent J.
        • et al.
        Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.
        Eur J Cancer. 2013; 49: 1374-1403
        • Brookman-May S.
        • May M.
        • Shariat S.F.
        • et al.
        Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN project).
        Eur Urol. 2013; 64: 472-477
        • Margulis V.
        • McDonald M.
        • Tamboli P.
        • et al.
        Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
        J Urol. 2009; 181: 2044-2051
        • Kreshover J.E.
        • Richstone L.
        • Kavoussi L.R.
        Renal cell recurrence for T1 tumors after laparoscopic partial nephrectomy.
        J Endourol. 2013; 27: 1468-1470
        • Huber J.
        • Herpel E.
        • Jakobi H.
        • et al.
        Two decades' experience with a prospective biobank for urologic oncology: research, clinical care, and the patients' view.
        Urol Oncol. 2013; 31: 990-996
        • Ljungberg B.
        • Bensalah K.
        • Canfield S.
        • et al.
        EAU guidelines on renal cell carcinoma: 2014 update.
        Eur Urol. 2015; 67: 913-924
        • Kovacs G.
        • Akhtar M.
        • Beckwith B.J.
        • et al.
        The Heidelberg classification of renal cell tumours.
        J Pathol. 1997; 183: 131-133
        • Clavien P.A.
        • Barkun J.
        • de Oliveira M.L.
        • et al.
        The Clavien-Dindo classification of surgical complications: five-year experience.
        Ann Surg. 2009; 250: 187-196
        • Lane B.R.
        • Campbell S.C.
        • Gill I.S.
        10-Year oncologic outcomes after laparoscopic and open partial nephrectomy.
        J Urol. 2013; 190: 44-49
        • Muramaki M.
        • Miyake H.
        • Sakai I.
        • et al.
        Age at diagnosis as a powerful predictor for disease recurrence after radical nephrectomy in Japanese patients with pT1 renal cell carcinoma.
        Int J Urol. 2011; 18: 121-125
        • Rioux-Leclercq N.
        • Karakiewicz P.I.
        • Trinh Q.D.
        • et al.
        Prognostic ability of simplified nuclear grading of renal cell carcinoma.
        Cancer. 2007; 109: 868-874
        • Sejima T.
        • Morizane S.
        • Hinata N.
        • et al.
        Fas expression in renal cell carcinoma accurately predicts patient survival after radical nephrectomy.
        Urol Int. 2012; 88: 263-270
        • Wosnitzer M.
        • Polland A.
        • Hai Q.
        • et al.
        Role of preoperative platelet level in clinical and pathological outcomes after surgery for renal cortical malignancies.
        BJU Int. 2011; 108: 73-79
        • Kim S.P.
        • Weight C.J.
        • Leibovich B.C.
        • et al.
        Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
        Urology. 2011; 78: 1101-1106
        • Brookman-May S.D.
        • May M.
        • Shariat S.F.
        • et al.
        Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma—results from a comprehensive multi-centre database (CORONA/SATURN-project).
        BJU Int. 2013; 112: 909-916
        • Tsui K.H.
        • Shvarts O.
        • Smith R.B.
        • et al.
        Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
        J Urol. 2000; 163: 1090-1095
        • Master V.A.
        • Gottschalk A.R.
        • Kane C.
        • et al.
        Management of isolated renal fossa recurrence following radical nephrectomy.
        J Urol. 2005; 174: 473-477
        • Esrig D.
        • Ahlering T.E.
        • Lieskovsky G.
        • et al.
        Experience with fossa recurrence of renal cell carcinoma.
        J Urol. 1992; 147: 1491-1494
        • Yohannan J.
        • Feng T.
        • Berkowitz J.
        • et al.
        Laparoscopic resection of local recurrence after previous radical nephrectomy for clinically localized renal-cell carcinoma: perioperative outcomes and initial observations.
        J Endourol. 2010; 24: 1609-1612
        • Hallemeier C.L.
        • Choo R.
        • Davis B.J.
        • et al.
        Long-term outcomes after maximal surgical resection and intraoperative electron radiotherapy for locoregionally recurrent or locoregionally advanced primary renal cell carcinoma.
        Int J Radiat Oncol Biol Phys. 2012; 82: 1938-1943
        • Habl G.
        • Uhl M.
        • Hensley F.
        • et al.
        Intraoperative electron radiation therapy (IOERT) in patients with locally recurrent renal cell carcinoma.
        Radiat Oncol. 2013; 8: 282
        • Albiges L.
        • Choueiri T.
        • Escudier B.
        • et al.
        A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer.
        Eur Urol. 2015; 67: 100-110